Skip to main content

Research Repository

Advanced Search

All Outputs (10)

Using patient experiences to evaluate care and expectations in lung cancer: analysis of the English Cancer Patient Experience Survey linked with the national cancer registry (2022)
Journal Article
Nartey, Y., Tata, L. J., Khakwani, A., Beattie, V., Beckett, P., Hubbard, R. B., & Stewart, I. (2022). Using patient experiences to evaluate care and expectations in lung cancer: analysis of the English Cancer Patient Experience Survey linked with the national cancer registry. Supportive Care in Cancer, 30(5), 4417-4428. https://doi.org/10.1007/s00520-022-06863-4

Purpose: Identification of unmet needs in person centred and supportive care could be limited by differences in experience across specific cancer populations. Using the experiences of people with lung cancer, we assess distinctions according to demog... Read More about Using patient experiences to evaluate care and expectations in lung cancer: analysis of the English Cancer Patient Experience Survey linked with the national cancer registry.

Is the English Cancer Patient Experience Survey representative? A comparative analysis with the National Lung Cancer Audit (2019)
Journal Article
Nartey, Y., Stewart, I., Khakwani, A., Beattie, V., Wilcock, A., Woolhouse, I., …Tata, L. J. (2020). Is the English Cancer Patient Experience Survey representative? A comparative analysis with the National Lung Cancer Audit. Lung Cancer, 140, 27-34. https://doi.org/10.1016/j.lungcan.2019.11.023

© 2019 Elsevier B.V. Objectives: Healthcare systems increasingly recognise the importance of service users’ perspectives for improving care organisation and delivery. The English Cancer Patient Experience Survey (CPES) is carried out annually, howeve... Read More about Is the English Cancer Patient Experience Survey representative? A comparative analysis with the National Lung Cancer Audit.

Factors influencing treatment selection and thirty-day mortality following chemotherapy for people with small cell lung cancer: an analysis of national audit data (2018)
Journal Article
Jones, G. S., McKeever, T. M., Hubbard, R. B., Khakwani, A., & Baldwin, D. R. (2018). Factors influencing treatment selection and thirty-day mortality following chemotherapy for people with small cell lung cancer: an analysis of national audit data. European Journal of Cancer, 103, 176-183. https://doi.org/10.1016/j.ejca.2018.07.133

Background Thirty-day mortality after treatment for lung cancer is a measure of unsuccessful outcome and where treatment should have been avoided. Guidelines recommend offering chemotherapy to individuals with small cell lung cancer (SCLC) who ha... Read More about Factors influencing treatment selection and thirty-day mortality following chemotherapy for people with small cell lung cancer: an analysis of national audit data.

Barriers to delivering advanced cancer nursing: a workload analysis of specialist nurse practice linked to the English National Lung Cancer Audit (2018)
Journal Article
Stewart, I., Leary, A., Tod, A., Borthwick, D., Khakwani, A., Hubbard, R., …Tata, L. (2018). Barriers to delivering advanced cancer nursing: a workload analysis of specialist nurse practice linked to the English National Lung Cancer Audit. European Journal of Oncology Nursing, 36, 103-111. https://doi.org/10.1016/j.ejon.2018.07.006

Purpose: Health services across the world utilise advanced practice in cancer care. In the UK, lung cancer nurse specialists (LCNS) are recognised as key components of quality care in national guidelines, yet access to LCNS contact is unequal and som... Read More about Barriers to delivering advanced cancer nursing: a workload analysis of specialist nurse practice linked to the English National Lung Cancer Audit.

Are working practices of lung cancer nurse specialists associated with variation in peoples’ receipt of anticancer therapy? (2018)
Journal Article
Stewart, I., Khakwani, A., Hubbard, R. B., Beckett, P., Borthwick, D., Tod, A., …Tata, L. J. (2018). Are working practices of lung cancer nurse specialists associated with variation in peoples’ receipt of anticancer therapy?. Lung Cancer, 123, 160-165. https://doi.org/10.1016/j.lungcan.2018.07.022

Objectives Treatment choices for people with lung cancer may be influenced by contact and engagement with lung cancer nurse specialists (LCNSs). We investigated how service factors, LCNS workload, and LCNS working practices may influence the recei... Read More about Are working practices of lung cancer nurse specialists associated with variation in peoples’ receipt of anticancer therapy?.

Apples and pears? A comparison of two sources of national lung cancer audit data in England (2017)
Journal Article
Khakwani, A., Jack, R. H., Vernon, S., Dickinson, R., Wood, N., Harden, S., …Hubbard, R. B. (2017). Apples and pears? A comparison of two sources of national lung cancer audit data in England. ERJ Open Research, 3(3), 00003-2017. https://doi.org/10.1183/23120541.00003-2017

In 2014, the method of data collection from NHS trusts in England for the National Lung Cancer Audit (NLCA) was changed from a bespoke dataset called LUCADA (Lung Cancer Data). Under the new contract, data are submitted via the Cancer Outcome and Ser... Read More about Apples and pears? A comparison of two sources of national lung cancer audit data in England.

Which patients are assessed by lung cancer nurse specialists? A national lung cancer audit study of over 128,000 patients across England (2016)
Journal Article
Khakwani, A., Hubbard, R. B., Beckett, P., Borthwick, D., Tod, A., Leary, A., …Tata, L. J. (in press). Which patients are assessed by lung cancer nurse specialists? A national lung cancer audit study of over 128,000 patients across England. Lung Cancer, 96, https://doi.org/10.1016/j.lungcan.2016.03.011

Background: Lung cancer nurse specialists (LCNS) are integral to the multidisciplinary clinical team, providing personalised physical and psycho-social interventions, and care management for people with lung cancer. The National Institute of Health a... Read More about Which patients are assessed by lung cancer nurse specialists? A national lung cancer audit study of over 128,000 patients across England.

The impact of the ‘hub and spoke’ model of care for lung cancer and equitable access to surgery (2014)
Journal Article
Khakwani, A., Rich, A. L., Powell, H. A., Tata, L. J., Stanley, R. A., Baldwin, D. R., …Hubbard, R. B. (2014). The impact of the ‘hub and spoke’ model of care for lung cancer and equitable access to surgery. Thorax, 70(2), https://doi.org/10.1136/thoraxjnl-2014-205841

Objectives: To determine the influence of where a patient is first seen (either surgical or non-surgical centre) and patient features on having surgery for non-small cell lung cancer (NSCLC). Design: Cross-sectional study from individual patients... Read More about The impact of the ‘hub and spoke’ model of care for lung cancer and equitable access to surgery.

Small-Cell Lung Cancer in England: Trends in Survival and Chemotherapy Using the National Lung Cancer Audit (2014)
Journal Article
Khakwani, A., Rich, A. L., Tata, L. J., Powell, H. A., Stanley, R. A., Baldwin, D. R., & Hubbard, R. B. (2014). Small-Cell Lung Cancer in England: Trends in Survival and Chemotherapy Using the National Lung Cancer Audit. PLoS ONE, 9(2), Article e89426. https://doi.org/10.1371/journal.pone.0089426

Background The purpose of this study was to identify trends in survival and chemotherapy use for individuals with small-cell lung cancer (SCLC) in England using the National Lung Cancer Audit (NLCA). Methods We used data from the NLCA database... Read More about Small-Cell Lung Cancer in England: Trends in Survival and Chemotherapy Using the National Lung Cancer Audit.

Treatment decisions and survival for people with small-cell lung cancer (2014)
Journal Article
Powell, H., Tata, L., Baldwin, D., Potter, V., Stanley, R., Khakwani, A., & Hubbard, R. (in press). Treatment decisions and survival for people with small-cell lung cancer. British Journal of Cancer, 110(4), https://doi.org/10.1038/bjc.2013.812

Background: Chemotherapy improves survival for many patients with SCLC, and hence it is important to understand variations in practice and outcomes for this treatment strategy. Methods: We used the National Lung Cancer Audit and Hospital Episodes... Read More about Treatment decisions and survival for people with small-cell lung cancer.